Complex Discovery

OCTOBER 19, 2024

Editor’s Note: Artificial intelligence (AI) is transforming the pharmaceutical industry, offering unprecedented opportunities to accelerate drug discovery, streamline clinical trials, and fortify intellectual property (IP) strategies.

Pharmaceuticals 111

Pharmaceuticals Discovery Government and Public Sector Chain Of Custody 111

IP Watchdog

MARCH 7, 2025

International Trade Commissions economic prong analysis for the domestic industry requirement of Section 337, finding that petitioners at the Patent Trial and Appeal Board have no self-executing discovery obligations to present evidence from parallel ITC proceedings, and more; strong global demand for AI chips buoys Broadcoms first quarter results; (..)

Discovery 52

Discovery Pharmaceuticals Evidence 52

Complex Discovery

JUNE 17, 2024

This case highlights critical issues surrounding product safety, transparency, and the ethical responsibilities of corporations, especially within the pharmaceutical industry. The broader implications of this settlement will likely influence similar litigations and regulatory practices in the pharmaceutical and consumer goods industries.

Litigation 111

Litigation Pharmaceuticals Manufacturing Evidence 111

Complex Discovery

NOVEMBER 3, 2024

As October 2024 concluded, it continues to be evident that the eDiscovery, cybersecurity, and information governance sectors are undergoing significant transformations. As AI becomes a critical tool in pharmaceutical innovation, it also presents challenges around data security, governance, and legal accountability. Read the update.

Government and Public Sector 69

Government and Public Sector Technology Cross-Examination Energy and Utilities 69

Forensic Psychologist

OCTOBER 25, 2015

Unlike many purported disorders that are promoted by researchers or the pharmaceutical industry, sex addiction is a bottoms-up movement, with people self-diagnosing themselves via self-help books or quick-and-dirty Internet surveys. Finally, and most critically, alarmist claims are made about a growing epidemic.

Objections 52

Objections Pharmaceuticals Construction Discovery 52